ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $575,207 | +54.7% | 1,170 | +22.6% | 0.07% | +61.0% |
| Q2 2023 | $371,802 | +5.2% | 954 | +0.5% | 0.04% | -2.4% |
| Q1 2023 | $353,578 | -4.1% | 949 | -2.5% | 0.04% | -14.3% |
| Q4 2022 | $368,602 | +33.6% | 973 | +24.6% | 0.05% | +22.5% |
| Q3 2022 | $276,000 | +2.6% | 781 | +10.0% | 0.04% | +8.1% |
| Q2 2022 | $269,000 | +25.1% | 710 | +4.0% | 0.04% | +42.3% |
| Q1 2022 | $215,000 | +7.0% | 683 | +2.9% | 0.03% | -10.3% |
| Q3 2021 | $201,000 | -49.1% | 664 | -49.4% | 0.03% | -50.8% |
| Q2 2021 | $395,000 | +605.4% | 1,313 | +591.1% | 0.06% | +293.3% |
| Q4 2020 | $56,000 | – | 190 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |